Visual Summaries of Landmark Clinical Trials
Home
»
Articles posted by admin
Author Archives:
admin
Generic selectors
Exact matches only
Exact matches only
Search in title
Search in title
Search in content
Search in content
Search in excerpt
Search in posts
Search in posts
Search in pages
Search in pages
Cardiology
Acute Coronary Syndrome
ATLAS ACS-2: Rivaroxaban after ACS
CAPRICORN Trial: Effect of carvedilol on outcome after MI in patients with LV dysfunction
CAST I: Use of Antiarrhythmics post-MI for Cardiac Arrhythmia Suppression
CHAMPION PHOENIX: Cangrelor in PCI
COMFORTABLE-AMI (2014) – Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute MI
COMMIT Trial: Metoprolol in Acute Myocardial Infarction
CULPRIT-SHOCK: Culprit lesion vs multivessel PCI in ACS with cardiogenic shock
CURE: Effects of Clopidogrel plus Aspirin in Patients with NSTEMI
EPHESUS: Eplerenone in patients with LV dysfunction after MI
IMPROVE IT (2015): Ezetimibe + statin in acute coronary syndrome (ACS)
ESSENCE: Enoxaparin vs Unfractionated Heparin for UA/NSTEMI
FRISC II Trial (2006): Invasive vs non-invasive treatment in unstable CAD
IABP-SHOCK II Trial (2012): Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
IMPROVE IT (2015): Ezetimibe + statin in acute coronary syndrome (ACS)
ISAR-REACT 5 Trial (2019) – Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
MADIT-II (2002): Prophylactic ICD in Patients with Myocardial Infarction and Reduced Ejection Fraction
MIRACL Trial (2001): Atorvastatin use for early recurrent ischemic events in ACS
OASIS-5 Trial (2006) -Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
OAT Trial (2006) – Coronary Intervention for Persistent Occlusion after Myocardial Infarction
ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes with Alirocumab after an ACS
PROVE IT Trial (2004): Intensive vs Moderate Lipid Lowering with Statins after ACS
RAPID-TnT Trial (2009) – 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes
SADHART Trial: Sertraline Use in Depression after ACS
SCOT-HEART Trial: Coronary CT Angiography and Risk of Myocardial Infarction
SMART-DATE Trial (2018): 6 vs 12 months of DAPT after PCI with DES in ACS
TIMACS Trial (2009): Early versus Delayed Invasive Intervention in ACS
TREAT Trial (2019)
TROPICAL-ACS Trial (2017)
ULTIMATE Trial: IVUS vs Angiography-Guided Implantation of DES
VALIANT Trial (2003): Valsartan, Captopril, or Both in Myocardial Infarction
VEST Trial: Vest Prevention of Early Death Trial
Amyloidosis
ATTR-ACT Trial (2018): Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.
Atrial Fibrillation
AATAC Trial (2016): Ablation vs. amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device
ALCOHOL-AF Trial: Impact of Alcohol Abstinence in Moderate Drinkers With Atrial Fibrillation
AF-CHF Trial (2008): Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
AFFIRM Trial: Rate control vs Rhythm control in Atrial Fibrillation
ARISTOTLE: Apixaban vs. warfarin in atrial fibrillation
AUGUSTUS Trial (2019): Antithrombotic therapy or PCI in Atrial Fibrillation
BRIDGE Trial (2015): Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
CABANA Trial: Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation
CASTLE-AF: Catheter Ablation for Atrial Fibrillation with Heart Failure
CRYSTAL-AF: Cryptogenic Stroke and Underlying Atrial Fibrillation
EMBRACE Trial (2014): Atrial fibrillation in patients with cryptogenic stroke
PROTECT AF Trial: Closure of the LAA versus warfarin therapy in patients with Atrial Fibrillation
FIRE AND ICE Trial (2016): Cryoballoon or RF ablation for paroxysmal atrial fibrillation
RE-DUAL PCI Trial (2017): Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
ROCKET-AF: Rivaroxaban vs. warfarin in atrial fibrillation
RACE II: Strict vs Lenient Control of Heart Rate in Atrial Fibrillation
CABG
Carotid Artery Stenosis
Coronary Artery Disease
Heart Failure
Hypertension
Implantable Devices
Lipids
Percutaneous Coronary Intervention
Peripheral Arterial Disease
Valvular Heart Disease
Dermatology
Actinic Keratosis
Melanoma
Emergency Medicine
Cardiac Arrest
Trauma
Endocrinology
Diabetes Mellitus
Thyroid Disorders
Gastroenterology
Cirrhosis
Gastrointestinal Bleeding
Nutrition
Obesity
Pancreatitis
Geriatrics
Delirium
Hematology
Anemia
Sickle Cell Disease
TTP
Venous Thromboembolism
Oncology
Cancer
Infectious Disease
HIV
Hepatitis C
Infections
Osteomyelitis
Sepsis
Nephrology
Cardiorenal Syndrome
Nephropathy
Dialysis
Neurology
Stroke
Pulmonary
Critical Care
Rheumatology
Surgery
Share this:
Tweet
WhatsApp
Print
FIRE AND ICE Trial (2016): Cryoballoon or RF ablation for paroxysmal atrial fibrillation
Post navigation
←
Older posts
–
About / Contact
All Clinical Trials
Contribute
Home
